A detailed history of Catalyst Funds Management Pty LTD transactions in Organon & Co. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 4,400 shares of OGN stock, worth $64,988. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,400
Holding current value
$64,988
% of portfolio
0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$18.65 - $23.03 $82,060 - $101,332
4,400 New
4,400 $84.2 Million
Q1 2024

Dec 04, 2024

SELL
$13.78 - $18.8 $52,364 - $71,440
-3,800 Reduced 86.36%
600 $11.3 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.76B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Catalyst Funds Management Pty LTD Portfolio

Follow Catalyst Funds Management Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalyst Funds Management Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Catalyst Funds Management Pty LTD with notifications on news.